Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Chimerix Inc
(NQ:
CMRX
)
0.8870
+0.0519 (+6.21%)
Streaming Delayed Price
Updated: 11:54 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
807,102
Open
0.8900
Bid (Size)
0.8634 (2)
Ask (Size)
0.8870 (4)
Prev. Close
0.8351
Today's Range
0.8602 - 0.9180
52wk Range
0.7500 - 1.300
Shares Outstanding
86,249,744
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CMRX Stock Earnings: Chimerix Meets EPS, Beats Revenue for Q2 2024
August 13, 2024
CMRX stock results show that Chimerix met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
August 13, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Performance
YTD
-7.60%
-7.60%
1 Month
-6.39%
-6.39%
3 Month
-8.54%
-8.54%
6 Month
-14.71%
-14.71%
1 Year
-7.60%
-7.60%
More News
Read More
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
August 06, 2024
Via
FinancialNewsMedia
Exposures
COVID-19
CMRX Stock Earnings: Chimerix Misses EPS for Q1 2024
May 01, 2024
Via
InvestorPlace
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Preview: Chimerix's Earnings
February 28, 2024
Via
Benzinga
Earnings Outlook For Chimerix
November 01, 2023
Via
Benzinga
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
August 06, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
August 06, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
May 30, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
May 01, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
April 24, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Appoints Marc D. Kozin to Board of Directors
March 21, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
February 29, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
February 22, 2024
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Appoints Lisa Decker to Board of Directors
December 29, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
December 04, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 24, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
November 16, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
November 02, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
October 26, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
September 27, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.